Post Transplant Study

Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients

NCT02555787 ·Status: COMPLETED

Observational Registry Study of Renal Transplant Patients

NCT01284257 ·Status: WITHDRAWN

Evaluation of Immunobiogram® as a Tool in Adjustment of Immunosuppressant Therapy for Renal Transplant

NCT03562845 ·Status: COMPLETED

Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.

NCT03978494 ·Status: WITHDRAWN ·Phase: PHASE1

European Transplant Registry of Senior Renal Transplant Recipients on Advagraf

NCT02558452 ·Status: NOT_YET_RECRUITING

Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients

NCT01320358 ·Status: COMPLETED ·Phase: PHASE2

" SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients"

NCT04945785 ·Status: ACTIVE_NOT_RECRUITING

Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients

NCT02500212 ·Status: COMPLETED ·Phase: PHASE4

A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.

NCT00758602 ·Status: COMPLETED ·Phase: PHASE4

A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant

NCT02057484 ·Status: COMPLETED

Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

NCT01935128 ·Status: COMPLETED ·Phase: PHASE4

Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics

NCT00902980 ·Status: COMPLETED

Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients

NCT03020589 ·Status: COMPLETED ·Phase: PHASE4

Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism

NCT01220050 ·Status: COMPLETED ·Phase: PHASE2

Identification of Patients With High Probability of Poorly Responding to Therapy With Mycophenolic Acid Prodrugs

NCT00978965 ·Status: COMPLETED

Calcineurin Inhibitor Sparing After Kidney Transplantation

NCT01062555 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)

NCT02490904 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

NCT00658359 ·Status: COMPLETED ·Phase: PHASE2

Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant

NCT02251691 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients

NCT00048152 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

NCT00933231 ·Status: COMPLETED ·Phase: PHASE3

Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients

NCT02866682 ·Status: COMPLETED ·Phase: PHASE4

Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study

NCT00895206 ·Status: COMPLETED ·Phase: PHASE4

A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients

NCT01033864 ·Status: COMPLETED ·Phase: PHASE4

Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk

NCT00138970 ·Status: COMPLETED ·Phase: PHASE4